Article
The in vivo effects of milrinone on the airways of cystic fibrosis mice and human subjects.
American journal of respiratory cell and molecular biology - 1 Jan 1999
Smith S N, Middleton P G, Chadwick S, Jaffe A, Bush K A, Rolleston S, Farley R, Delaney S J, Wainwright B, Geddes D M, Alton E W
Abstract excerpt
Previous studies have indicated that milrinone, a specific type III phosphodiesterase inhibitor, may be able to induce chloride secretion in cystic fibrosis (CF) tissues. We have now assessed the effect of this agent in vivo on the nasal epithelium of CF mutant mice and also in the nose and lungs of human subjects with CF. Wild-type mice showed a small hyperpolarization of the nasal potential difference (PD) in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
